Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-014964
Filing Date
2024-05-31
Accepted
2024-05-31 08:52:44
Documents
1
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 form4-05312024_120540.html 4  
1 form4-05312024_120540.xml 4 4060
  Complete submission text file 0001415889-24-014964.txt   5583
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Issuer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O HARMONY BIOSCIENCES HOLDINGS, INC. 630 W. GERMANTOWN PIKE, SUITE 215 PLYMOUTH MEETING PA 19462
Business Address
Anastasiou Peter (Reporting) CIK: 0001999888 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39450 | Film No.: 241007842